3Safety of Medicines: A guide to detecting and reporting ADR - why health professionals need to take actions[EB/OL].http: //www.who.int/medicines/library/qsm/who- edm- qsm- 2002- 2/esdsafety.pdf, 2002: 7.
4Adverse drug events: The magnitude of health risk is uncertain because of limited incidence data [EB/OL].http: //www.gao.gov/new.items/he00021.pdf, 2000: 35～ 36.
5Lagnaoui R, Moore N, Fach J, et al.Aderse drug reactions in a department of systemic diseases- oriented internal medicine: prevalence, incidence, direct costs and avoilability[J].Eur J Clin Pharmacol, 2000, 55: 181.
6Lundkvist J, Jonsson B.Pharmacoeconomics of adverse drug reactions[J].Fundamental &Clinical Pharmacology, 2004, 18( 3): 275.
7Kimberly S. Plake, A course on Chronic Illness: learning the Patient's Perspective[J]. American Journal of Pharmaceutical Education, 2003, 67( 1 ) :31.
